Pharmaceutical care services in hospitals of Kuwait

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 9, Issue 2, 2006, Pages 10-18

  Awad, Abdelmoneim ^a   Al Ebrahim, Shareefa ^b   Abahussain, Eman ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

^b MINISTRY OF HEALTH   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ADULT; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH SURVEY; HOSPITAL CARE; HUMAN; INTERVIEW; KUWAIT; MALE; PATIENT CARE; PATIENT COUNSELING; PHARMACEUTICAL CARE; PHARMACIST; POPULATION DISTRIBUTION; PRESCRIPTION; PROFESSIONAL PRACTICE; PUBLIC HEALTH SERVICE; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 33646824203     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Hepler CD and Strand LM. Opportunities and Responsibilities in pharmaceutical care. Am J Hosp Pharm, 47:533-543, 1990.
2. Johnson J and Bootman J. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm, 54: 554-558, 1997.
3. Cipolle RJ, Strand LM and Morley PC Outcomes of pharmaceutical practice, in Pharmaceutical care practice. McGraw-Hill, New York:, 1998.
4. Schumock G and Michaud J. Re-engineering; an opportunity to advance clinical practice in a community hospital. Am J Health Syst pharm, 56: 1945-49, 1999.
5. Bluml BM, McKinney JM and Cziraky MJ. Pharmaceutical care services and results in Project Impact: Hyperlipidemia. J Am Pharm Assoc, 40: 157-65, 2000.
6. Berenguer B., Lacasa C., de La Matta M.J and Martin-Calaro M.J. Pharmaceutical care: Past, Present and Future. _Journal of Current Pharmaceutical Design, 10: 3931-3946, 2004.
7. Roughead EE, Semple SJ and Vitry AI Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes. IJPP, 13: 53-70, 2005.
8. Hogerzeil HV, Bimo, and Ross-Degnan D. Field tests for rational drug use in twelve developing countries. Lancet, 342: 1408-1410, 1993.
9. Calva JJ, Sifuentes-Osornio J and Ceron C. Antimicrobial resistance in fecal flora: Longitudinal community-based surveillance of children from urban Mexico. Antimicrob Agents Chemother, 40:1699-702, 1996.
10. Quick JD, Hogerzeil HV, Velasquez G, and Rago L. Twenty-five years of Essentials medicines. Bulletin of the World Health Organization, 80(11):913-914, 2002.
11. Awad A.I., Eltayeb I.B., Matowe L and Thalib L. Self medication with Antibiotics and Antimalarials in the community of Khartoum State, Sudan. J Pharm Pharmaceut Sci 8(2):326-331, 2005.
12. Eltayeb I.B., Awad A.I., Mohamed-Salih M.S., Daffa-Alla, M.A., Ahmed M.B., Ogail, M.A., Matowe L. Changing the prescribing patterns of sexually transmitted infections in the White Nile Region of Sudan. Sex Transm Infect 81 (5): 426-427, 2005.
13. Awad AI, Eltayeb IB, Baraka OZ. Changing antibiotics prescribing practices in health centers of Khartoum State, Sudan. Eur J Clin Pharmacol, 3: 1-8, 2006.
14. Calvin H.Knowlton and Richard P.Penna. Pharmaceutical care.2nd edition. PA:Chapman & Hall, New York, 2003.
15. Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: Practice and research from around the world. Ann Pharmacother 39:1539-1541, 2005.
16. International. Pharmaceutical Federation. Good Pharmacy Practice. Available at URL: http://213.206.88.26/www2/subsections/ index.php?page=menu_goodpharmacypractice.
17. International Pharmaceutical Federation. Good pharmacy practice (GGP) in developing countries: Recommendations for step-wise implementation. Available at URL: http://213.206.88.26/www2/pdf/gpp/GPP_CPS_Report.pdf.
18. World Health Organization. The role of pharmacist in self-care and self-medication. Report of the 4th WHO Consultative Group on the role of the Pharmacist. WHO/DAP/98.13, 1998
19. Abood RR. Errors in pharmacy practice, US pharmacist, 21(3): 122-132, 1996.
20. Sara Tulip and David Campbell. Evaluating pharmaceutical care in hospitals. Hosp Pharm, 8: 275-7, 2001.
21. Gattis WA, Hassebald V, Whellan DJ, et al. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team. Arch Intern Med, 159: 1939-45, 1999.
22. Leape LL, Cullen DJ, Dempesy Clapp M, et al. Pharmacists participation on physician rounds and adverse drug events in the intensive care unit. JAMA, 282: 267-70, 1999.
23. Carroll NV and Gagnon JP. The relationship between patient variables and frequency of pharmacist counselling. Drug Intell Clin Pharm, 17 (9): 648-52, 1983.
24. Liu MY, Jennings JP, Samuelson WM, et al. Asthma patients' satisfaction with the frequency and content of pharmacist counselling. J Am Pharm Assoc, 39 (4): 493-8, 1999.
25. Dixie Farley. FDA proposes program to give patients better medication information. U.S Food and Drug Administration. Available at URL: http://www.fda.gov/fdac/features/995_medinofo.html.
26. Fritsch MA and Lamp KC. Low pharmacist counselling rates in the Kana City, Missouri, metropolitan area. Ann Pharmacother, 31 (9):984-91, 1997.
27. Bonnie Svarstad. Evaluation of patient counselling in US pharmacies: effect of pharmacist characteristics, pharmacy conditions and regulation. The Pharmaceutical Journal, 273 (7313):266-267, 2004.
28. Rutter PM. Pharmacist work patterns: Are they affected by staffing levels and prescription numbers. International J of Pharm Pract 10 (suuppl): R 49, 2002.